Home › Research › Inflammation and the immune system
UCH-L1 in Alzheimer’s Disease: A Crucial Player in Dementia-Associated Mechanisms
Elisa Porchietto, Giulia Morello, Giulia Cicilese, Innocenzo Rainero, Elisa Rubino, Elena Tamagno, Silvia Boschi, Michela Guglielmotto. International Journal of Molecular Sciences, 2025-09-16
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) is a critical deubiquitinating enzyme that is highly expressed in the central nervous system, where it participates in protein degradation and turnover as part of the ubiquitin-proteasome system (UPS). Convincing evidence supports the role of UCH-L1 dysfunction in several neurodegenerative disorders, given its unique position at the crossroad of several aetiopathogenic pathways, including those implicated in Alzheimer's disease (AD) onset. Indeed, UCH-L1 depletion correlates with decreased levels of triggering receptor expressed on myeloid cells 2 (TREM2), with consequent effects on neuroinflammation. Notably, UCH-L1 can affect the level of phosphorylated tau protein, thus contributing to the formation of neurofibrillary tangles (NFTs). In addition, UCH-L1 influences β-Secretase 1 (BACE1) expression, resulting in the abnormal accumulation of amyloid-β plaques in brain parenchyma. These findings underline UCH-L1's centrality in maintaining the homeostasis of protein folding and aggregation, which are significantly impaired in AD and AD-related dementias. Given these assumptions, UCH-L1 is recognized as a potential biomarker for AD, highlighting its relevance in governing the fate of crucial pathological mediators of cognitive impairment and neurodegeneration. Herein, we contextualize the involvement of UCH-L1 in different dementia-associated pathways and summarize the state of the art of UCH-L1 as a biomarker for AD diagnosis.
What this study adds
Evidence grade: Low
This review describes how the enzyme UCH-L1 is involved in protein degradation and is linked to tau tangles, amyloid accumulation and neuroinflammation in Alzheimer's disease. It presents UCH-L1 as a potential biomarker but reports no treatment tested in patients.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Porchietto, E., Morello, G., Cicilese, G., Rainero, I., Rubino, E., Tamagno, E., et al. (2025). UCH-L1 in Alzheimer’s Disease: A Crucial Player in Dementia-Associated Mechanisms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189012
Vancouver
Porchietto E, Morello G, Cicilese G, Rainero I, Rubino E, Tamagno E, et al. UCH-L1 in Alzheimer’s Disease: A Crucial Player in Dementia-Associated Mechanisms. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189012. PMID: 41009578.
BibTeX
@article{porchietto2025-41009578,
author = {Porchietto, Elisa and Morello, Giulia and Cicilese, Giulia and Rainero, Innocenzo and Rubino, Elisa and Tamagno, Elena and Boschi, Silvia and Guglielmotto, Michela},
title = {{UCH-L1 in Alzheimer’s Disease: A Crucial Player in Dementia-Associated Mechanisms}},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26189012},
pmid = {41009578},
url = {https://doi.org/10.3390/ijms26189012}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- These findings underline UCH-L1's centrality in maintaining the homeostasis of protein folding and aggregation, which are significantly impaired in AD and AD-related dementias.
Why it matters
This review describes how the enzyme UCH-L1 is involved in protein degradation and is linked to tau tangles, amyloid accumulation and neuroinflammation in Alzheimer's disease. It presents UCH-L1 as a potential biomarker but reports no treatment tested in patients.
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International Journal of Molecular Sciences) |
| Journal's citation record | 3 / 4 | International Journal of Molecular Sciences: journal h-index 426 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 12 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 6.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 12 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Michela Guglielmotto: h-index 28 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Turin: institution h-index 903 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41009578) |
| Free to read | 2 / 2 | Free to read |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3390/ijms26189012
- PubMed: 41009578
- Original source →
- Free full text: International Journal of Molecular Sciences →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Inflammation and the immune system from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.